journal article·2020-10-23

Versatile and High-Throughput Strategy for the Quantification of Proteins Bound to Nanoparticles

Romane Oliverio, Benoît Liberelle, Frédéric Murschel, Araceli Garcia-Ac, Xavier Banquy, Gregory De Crescenzo

ACS Applied Nano Materials· Volume 3· Issue 10
Publisher page

Abstract

Biofunctionalized nanomaterials have been extensively studied as a tool for a wide range of applications in biomedical fields. Despite many existing strategies to conjugate proteins to colloidal particles, determining the grafting efficiency—that is, the amount of protein conjugated to the surface of a nanoparticle (NP)—remains challenging. Formulations for biomedical applications are subjected to strict constraints, and a lack of precise characterization can prevent otherwise promising formulations to be explored further. Here, we propose a simple approach to precisely measure the grafting efficiency of biological molecules on the surface of three types of widely used NPs: polymeric NPs, inorganic NPs, and metallic NPs. This approach relies on the simultaneous hydrolysis of the grafted protein and the NP degradation in acidic conditions, followed by a spectrophotometric quantification of primary amines in solution. This strategy can be applied to any type of protein and does not require any labeling agent. It can be performed in a high-throughput manner as a routine experiment and only requires a conventional oven and a microplate reader.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery · Advanced Biosensing Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Groupe de Recherche en Sciences et Technologies Biomédicales (GRSTB), Bio-P2 Research Unit, École Polytechnique de Montréal, Montréal H3T 1J4, Québec, Canada

Canadian Research Chair in Bioinspired Materials, Faculty of Pharmacy, Université de Montréal, Montréal H3T 1J4, Québec, Canada

Funding

Fonds de Recherche du Qu?bec - Nature et Technologies · Canada Research Chairs · Canada First Research Excellence Fund · Natural Sciences and Engineering Research Council of Canada · TransMedTech Institute · Biomedical Science and Technology Research Group

References (63)

Show source-provided references
1. 10.1021/ja104317710.1021/ja1043177 ↗
2. 10.1038/nnano.2013.18110.1038/nnano.2013.181 ↗
3. 10.1116/1.491356610.1116/1.4913566 ↗
4. 10.1039/c2an36467k10.1039/c2an36467k ↗
5. 10.1002/ppsc.20170013410.1002/ppsc.201700134 ↗
6. 10.1021/acs.analchem.7b0122910.1021/acs.analchem.7b01229 ↗
7. 10.1039/c5ay01775k10.1039/c5ay01775k ↗
8. 10.1038/ncomms1312110.1038/ncomms13121 ↗
9. 10.1039/c7tb01385j10.1039/c7tb01385j ↗
10. 10.1021/mp900284c10.1021/mp900284c ↗
11. 10.1039/c5nr02625c10.1039/c5nr02625c ↗
12. 10.1021/acs.accounts.6b0057910.1021/acs.accounts.6b00579 ↗
13. 10.1039/c6nr05455b10.1039/c6nr05455b ↗
14. 10.3762/bjnano.2.4310.3762/bjnano.2.43 ↗
15. 10.1038/nnano.2009.19510.1038/nnano.2009.195 ↗
16. 10.1039/c9nr10218c10.1039/c9nr10218c ↗
17. 10.1021/ja073197510.1021/ja0731975 ↗
18. 10.1016/j.ymeth.2014.01.01010.1016/j.ymeth.2014.01.010 ↗
19. 10.1080/0892701080205847110.1080/08927010802058471 ↗
20. 10.1002/cyto.a.2013810.1002/cyto.a.20138 ↗
21. 10.1016/j.talanta.2019.05.10410.1016/j.talanta.2019.05.104 ↗
22. 10.1021/bc200596a10.1021/bc200596a ↗
23. 10.1371/journal.pone.007420010.1371/journal.pone.0074200 ↗
24. 10.1007/s00216-016-9510-310.1007/s00216-016-9510-3 ↗
25. 10.1016/j.mex.2019.09.01510.1016/j.mex.2019.09.015 ↗
26. 10.1021/acs.biomac.9b0013710.1021/acs.biomac.9b00137 ↗
27. 10.1021/acs.bioconjchem.9b0073710.1021/acs.bioconjchem.9b00737 ↗
28. 10.1039/c8ra03487g10.1039/c8ra03487g ↗
29. 10.1016/j.aca.2017.08.00410.1016/j.aca.2017.08.004 ↗
30. Noble J. E. · 2009 · 463 · 73
31. Walker J. M. · 199610.1007/978-1-60327-259-9 ↗
32. Aitken A. · 2009 · 310.1007/978-1-59745-198-7_1 ↗
33. Walker J. M. · 2009 · 1110.1007/978-1-59745-198-7_3 ↗
34. Kruger N. J. · 2009 · 1710.1007/978-1-59745-198-7_4 ↗
35. 10.1373/clinchem.2005.05153210.1373/clinchem.2005.051532 ↗
36. Fields R. · 1972 · 25 · 464
37. 10.1126/science.178.4063.87110.1126/science.178.4063.871 ↗
38. 10.1006/abio.1996.992010.1006/abio.1996.9920 ↗
39. Davidson I. · 1997 · 119
40. Hunziker P. · 2011
41. 10.1016/j.addr.2016.06.01810.1016/j.addr.2016.06.018 ↗
42. 10.2147/IJN.S1491210.2147/IJN.S14912 ↗
43. 10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
44. 10.1039/b712170a10.1039/b712170a ↗
45. 10.1016/j.drudis.2012.06.01410.1016/j.drudis.2012.06.014 ↗
46. 10.1007/s12274-008-8018-310.1007/s12274-008-8018-3 ↗
47. 10.1016/s0169-4332(00)00304-410.1016/s0169-4332(00)00304-4 ↗
48. 10.1016/j.biomaterials.2004.02.01210.1016/j.biomaterials.2004.02.012 ↗
49. 10.1016/j.chroma.2010.10.06210.1016/j.chroma.2010.10.062 ↗
50. 10.1080/19420862.2019.158101710.1080/19420862.2019.1581017 ↗
51. 10.1116/1.497887110.1116/1.4978871 ↗
52. 10.1021/acs.langmuir.8b0065210.1021/acs.langmuir.8b00652 ↗
53. 10.1016/j.ijpharm.2019.02.03910.1016/j.ijpharm.2019.02.039 ↗
54. 10.1002/jps.2325910.1002/jps.23259 ↗
55. 10.1038/nprot.2008.110.1038/nprot.2008.1 ↗
56. 10.1016/0003-2697(66)90275-210.1016/0003-2697(66)90275-2 ↗
57. 10.1016/j.aca.2014.04.05710.1016/j.aca.2014.04.057 ↗
58. 10.1021/acs.bioconjchem.8b0068410.1021/acs.bioconjchem.8b00684 ↗
59. 10.1016/j.molimm.2012.05.01110.1016/j.molimm.2012.05.011 ↗
60. DrugBank Database Trastuzumab. https://www.drugbank.ca/drugs/DB00072 (accessed June 25, 2020).
61. Hunt S. · 1985 · 37610.1007/978-94-009-4832-7_12 ↗
62. 10.1039/c6an00193a10.1039/c6an00193a ↗
63. 10.1021/acs.bioconjchem.8b0036610.1021/acs.bioconjchem.8b00366 ↗